Elevation of striatal interleukin-6 and serum corticosterone contents in MPTP-treated mice

被引：22

作者：

Kaku, K ^{[1
]}

Shikimi, T ^{[1
]}

Kamisaki, Y ^{[1
]}

Shinozuka, K ^{[1
]}

Ishino, H ^{[1
]}

Okunishi, H ^{[1
]}

Takaori, S ^{[1
]}

机构：

[1] Shimane Med Univ, Dept Psychiat, Izumo, Shimane 6938501, Japan

来源：

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 1999年 / 26卷 / 09期

关键词：

corticosterone; interleukin-1; beta; interleukin-6; MPTP; striatum;

D O I：

10.1046/j.1440-1681.1999.03113.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

1. Changes in the content of striatal interleukins (IL-1 beta and IL-6) and serum corticosterone in relation to deterioration of the dopaminergic system induced by 1-methyl-1-phenyl-2,2,3,6-tetrahydropyridine (MPTP; a dopaminergic neurotoxin; 20 mg/kg i.p., four administrations/12 h) in C57BL/6J mice were investigated, 2. Striatal dopamine, IL-1 beta, IL-6 and serum corticosterone were measured on days 1 and 7 post-MPTP. 3, Dopamine depletion was more severe on day 7 than on day 1 post-treatment. 4. Increases in IL-6 were observed on days 1 and 7 post-MPTP. The increase in striatal IL-6 content varied with the extent of dopamine depletion, although the IL-1 beta concentration remained unchanged compared with control values on days 1 and 7 post-treatment. 5. Serum corticosterone was not different from control on day 1 post-MPTP. However. marked increases in the serum corticosterone were observed on day 7 post-treatment. 6, These results suggest that changes in striatal IL-6 and serum corticosterone are closely associated with the severity of MPTP-induced dopaminergic degeneration.

引用

页码：680 / 683

页数：4

共 34 条

[21] INTERLEUKIN-6 AS A NEUROTROPHIC FACTOR FOR PROMOTING THE SURVIVAL OF CULTURED CATECHOLAMINERGIC NEURONS IN A CHEMICALLY DEFINED MEDIUM FROM FETAL AND POSTNATAL RAT MIDBRAINS [J].

KUSHIMA, Y ;

HAMA, T ;

HATANAKA, H .

NEUROSCIENCE RESEARCH, 1992, 13 (04) :267-280

[22]

LOWRY OH, 1951, J BIOL CHEM, V193, P265

[23] INCREASE OF PLASMA ADRENOCORTICOTROPIN AND CORTISOL IN 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP)-TREATED DOGS [J].

MIZOBUCHI, M ;

HINENO, T ;

KAKIMOTO, Y ;

HIRATANI, K .

BRAIN RESEARCH, 1993, 612 (1-2) :319-321

[24] Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease [J].

Mogi, M ;

Harada, M ;

Narabayashi, H ;

Inagaki, H ;

Minami, M ;

Nagatsu, T .

NEUROSCIENCE LETTERS, 1996, 211 (01) :13-16

[25] INTERLEUKIN-1-BETA, INTERLEUKIN-6, EPIDERMAL GROWTH-FACTOR AND TRANSFORMING GROWTH-FACTOR-ALPHA ARE ELEVATED IN THE BRAIN FROM PARKINSONIAN-PATIENTS [J].

MOGI, M ;

HARADA, M ;

KONDO, T ;

RIEDERER, P ;

INAGAKI, H ;

MINAMI, M ;

NAGATSU, T .

NEUROSCIENCE LETTERS, 1994, 180 (02) :147-150

[26] CHARACTERIZATION OF THE ORIGINS OF ASTROCYTE RESPONSE TO INJURY USING THE DOPAMINERGIC NEUROTOXICANT, 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [J].

OCALLAGHAN, JP ;

MILLER, DB ;

REINHARD, JF .

BRAIN RESEARCH, 1990, 521 (1-2) :73-80

[27] 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP)-INDUCED ASTROGLIOSIS DOES NOT REQUIRE ACTIVATION OF ORNITHINE DECARBOXYLASE [J].

OCALLAGHAN, JP ;

SEIDLER, FJ .

NEUROSCIENCE LETTERS, 1992, 148 (1-2) :105-108

[28] IMMUNOREGULATORS IN THE NERVOUS-SYSTEM [J].

PLATASALAMAN, CR .

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1991, 15 (02) :185-215

[29] INCREASED STRIATAL LIPID-PEROXIDATION AFTER INTRACEREBROVENTRICULAR MPP PLUS ADMINISTRATION TO MICE [J].

ROJAS, P ;

RIOS, C .

PHARMACOLOGY & TOXICOLOGY, 1993, 72 (06) :364-368

[30] THE HYPOTHALAMUS IN MPTP-INDUCED PARKINSONISM [J].

SANDYK, R ;

IACONO, RP ;

KAY, SR .

ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1990, 11 (04) :367-372

← 1 2 3 4 →